Eugene

[email protected]

LATEST

Wacker Buys Dutch Biotech Plant; Invests in Pharmaceutical-Protein Business
By

By
Wacker Chemie, a Munich, Germany-headquartered company, has acquired from SynCo Bio Luxembourg, a contract manufacturing organization, a Dutch site for manufacturing biopharmaceuticals, live microbial products, and vaccines, plus associated business. …

Neopac To Build HQ in North Carolina
By

By
Neopac US, a manufacturer of primary packaging for the pharmaceutical and cosmetics industries, has selected Wilson, North Carolina as the location for its first US manufacturing plant and new North…

West Pharmaceuticals in Vial Supply Pact
By

By
West Pharmaceuticals, an Exton, Pennsylvania-headquartered manufacturer of packaging and delivery systems for injectable drugs and healthcare products, and Stevanato Group, through Ompi, its specialist in glass primary packaging for the…

Quotient Sciences Integrates Pharmaterials Acquisitions
By

By
Quotient Sciences, a Nottingham, UK-based contract development and manufacturing organization (CDMO), has completed the integration and rebrand of Pharmaterials, a CDMO based in Reading, UK. Quotient Sciences acquired Pharmaterials in…

MilliporeSigma, Oxford University Partner in Vaccine Mfg
By

By
MilliporeSigma has partnered with Oxford University’s Jenner Institute to develop more scalable vaccine-manufacturing processes. Separately, MilliporeSigma is developing plans for a vaccine-manufacturing facility in Africa. The partners intend to improve…

BMS, Novartis Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Bristol-Myers Squibb and Novartis. Editor’s Note: This article was updated on a continuous basis for news…

BMS, Illumina Partner on Companion Diagnostics
By

By
Bristol-Myers Squibb (BMS) and Illumina, a San Diego, California-headquartered company developing and commercializing systems for analysis of genetic variation and function, have partnered to use Illumina’s sequencing technology to develop…

Sanofi To Build New $431-Million Vaccine-Manufacturing Facility
By

By
Sanofi is investing EUR 350 million ($431 million) for the construction of a new vaccine-manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario.  The new facility will allow…

Pfizer To Relocate HQ To New Building in NYC
By

By
Pfizer has decided to relocate its New York City headquarters to a new building in the city. The company signed a 20-year lease for The Spiral, an office tower being…

Amgen To Build A New Manufacturing Plant in Rhode Island
By

By
Amgen plans to build a new biomanufacturing plant at its campus in West Greenwich, Rhode Island. In January 2018, Amgen announced a five-year capital investment plan of $3.5 billion, which…